Reply to letter on Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study

被引:6
|
作者
Beltran-Corbellini, A. [1 ]
Chico-Garcia, J. L. [1 ]
Martinez-Poles, J. [2 ,3 ]
Rodriguez-Jorge, F. [1 ]
Alonso-Canovas, A. [1 ]
机构
[1] Univ Hosp Ramon y Cajal, Dept Neurol, Madrid, Spain
[2] Hosp La Luz, Dept Neurol, Madrid, Spain
[3] Univ Hosp Clin San Carlos, Inst Sanit & Biomed Res Clin San Carlos IdISSC, Neurol Disorders Study Grp, Madrid, Spain
关键词
case–control study; coronavirus infection; PCR; smell disorders; taste disorders;
D O I
10.1111/ene.14359
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: Specific respiratory tract infections, including COVID-19, may cause smell and/or taste disorders (STDs) with increased frequency. The aim was to determine whether new-onset STDs are more frequent amongst COVID-19 patients than influenza patients. Method: This was a case–control study including hospitalized patients of two tertiary care centres. Consecutive patients positive for COVID-19 polymerase chain reaction (cases) and patients positive for influenza polymerase chain reaction (historical control sample) were assessed during specific periods, employing a self-reported STD questionnaire. Results: Seventy-nine cases and 40 controls were included. No significant differences were found in basal features between the two groups. New-onset STDs were significantly more frequent amongst cases (31, 39.2%) than in the control group (5, 12.5 %) [adjusted odds ratio 21.4 (2.77–165.4, P = 0.003)]. COVID-19 patients with new-onset STDs were significantly younger than COVID-19 patients without STDs (52.6 ± 17.2 vs. 67.4 ± 15.1, P < 0.001). Amongst COVID-19 patients who presented STDs, 22 (70.9%) recalled an acute onset and it was an initial manifestation in 11 (35.5%). Twenty-five (80.6%) presented smell disorders (mostly anosmia, 14, 45.2%) and 28 (90.3%) taste disorders (mostly ageusia, 14, 45.2%). Only four (12.9 %) reported concomitant nasal obstruction. The mean duration of STD was 7.5 ± 3.2 days and 12 patients (40%) manifested complete recovery after 7.4 ± 2.3 days of onset. Conclusion: New-onset STDs were significantly more frequent amongst COVID-19 patients than influenza patients; they usually had an acute onset and were commonly an initial manifestation. The use of STD assessment in anamnesis as a hint for COVID-19 and to support individuals’ self-isolation in the current epidemic context is suggested. © 2020 European Academy of Neurology
引用
收藏
页码:E34 / E34
页数:1
相关论文
共 50 条
  • [31] Determination of objective taste perception among Iranian medical sciences students during COVID-19 pandemic in Yazd, Eastern Iran: a case-control pilot study
    Hajimaghsoodi, Samira
    Paydar, Elham
    Owlia, Fatemeh
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [32] Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case-Control Pilot Study
    Piscitani, Luca
    Del Pinto, Rita
    Basili, Andrea
    Tunno, Marilena
    Ferri, Claudio
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (02) : 163 - 167
  • [33] Virological and clinical features of acute respiratory failure associated with COVID-19 in pregnancy: a case-control study
    Richard, Jean-Christophe
    Frobert, Emilie
    Destras, Gre'gory
    Yonis, Hodane
    Mezidi, Mehdi
    Dhelft, Francois
    Trouillet-Assant, Sophie
    Bastard, Paul
    Gervais, Adrian
    Danjou, William
    Aubrun, Frederic
    Roumieu, Fanny
    Josset, Laurence
    Labaune, Jean-Marc
    Bal, Antonin
    Simon, Bruno
    Casanova, Jean-Laurent
    Lina, Bruno
    Picaud, Jean-Charles
    Dupont, Corinne
    Huissoud, Cyril
    Bitker, Laurent
    CRITICAL CARE AND RESUSCITATION, 2022, 24 (03) : 242 - 250
  • [34] Development and validation of an early warning score to identify COVID-19 in the emergency department based on routine laboratory tests: a multicentre case-control study
    Boer, Arjen-Kars
    Deneer, Ruben
    Maas, Maaike
    Ammerlaan, Heidi S. M.
    van Balkom, Roland H. H.
    Thijssen, Wendy A. H. M.
    Bennenbroek, Sophie
    Leers, Mathie
    Martens, Remy J. H.
    Buijs, Madelon M.
    Kerremans, Jos J.
    Messchaert, Muriel
    van Suijlen, Jeroen J.
    van Riel, Natal A. W.
    Scharnhorst, Volkher
    BMJ OPEN, 2022, 12 (08):
  • [35] Evaluation of the COVID-19 pandemic effect on the development of somatic symptoms in patients with mood disorders: a case-control study
    Shahini, N.
    Ghasemzadeh, M.
    Javan, M.
    Salimi, Z.
    NEW MICROBES AND NEW INFECTIONS, 2021, 43
  • [36] Increased luminal area of large conducting airways in patients with COVID-19 and post-acute sequelae of COVID-19: a retrospective case-control study
    Zaremba, Solomiia
    Miller, Alex J.
    Ovrom, Erik A.
    Senefeld, Jonathon W.
    Wiggins, Chad C.
    Dominelli, Paolo B.
    Ganesh, Ravindra
    Hurt, Ryan T.
    Bartholmai, Brian J.
    Welch, Brian T.
    Ripoll, Juan G.
    Joyner, Michael J.
    Ramsook, Andrew H.
    JOURNAL OF APPLIED PHYSIOLOGY, 2024, 137 (05) : 1168 - 1174
  • [37] Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
    Sebastian, Shaji
    Walker, Gareth J.
    Kennedy, Nicholas A.
    Conley, Thomas E.
    Patel, Kamal, V
    Subramanian, Sreedhar
    Kent, Alexandra J.
    Segal, Jonathan P.
    Brookes, Matthew J.
    Bhala, Neeraj
    Gonzalez, Haidee A.
    Hicks, Lucy C.
    Mehta, Shameer J.
    Lamb, Christopher A.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (04): : 271 - 281
  • [38] MRI of Cerebrovascular Injury Associated With COVID-19 and Non-COVID-19 Acute Respiratory Distress Syndrome: A Matched Case-Control Study
    Shoskes, Aaron
    Huang, Merry
    Gedansky, Aron
    Hassett, Catherine
    Buletko, A. Blake
    Duggal, Abhijit
    Uchino, Ken
    Cho, Sung-Min
    CRITICAL CARE MEDICINE, 2022, 50 (11) : 1638 - 1643
  • [39] Neuropathological findings in COVID-19 vs. non-COVID-19 acute respiratory distress syndrome-A case-control study
    Humayun, Mariyam
    Zhang, Lucy
    Zaikos, Thomas D.
    Kannapadi, Nivedha
    Suarez, Jose I.
    Hager, David N.
    Troncoso, Juan C.
    Cho, Sung-Min
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [40] Atorvastatin Reduces the Severity of COVID-19: A Nationwide, Total Population-Based, Case-Control Study
    Cho, Dong-Hyuk
    Choi, Jimi
    Gwon, Jun Gyo
    COVID, 2022, 2 (03): : 398 - 406